By Robert Hand (robert.hand@rxcomms.com) As a health economist and outcomes researcher, you may work primarily within a single country. Naturally, you know the economic, regulatory, and management issues of that…
Details
By Kevin Frick (kevin.frick@rxcomms.com) It is ironic that we should have to answer the question: “what is the value of outcomes research?” when outcomes research is a key component of…
Details
By Robert Hand (robert.hand@rxcomms.com) Under the title Legacy of Leadership, the American Medical Writers Association (AMWA) held its 67th Annual Conference on October 11–13 in Atlanta, Georgia. About 1000 medical…
Details
By David Woods (david.woods@rxcomms.com) On January 1st 2006, Dr Dennis Gross retired from Merck after 28 years; the following day, he took up his present position as Associate Dean, Masters…
Details
Our HOC People person this month, Dennis M. Gross, PhD, is an associate dean at Thomas Jefferson University where he also teaches courses in pharmacology and toxicology. He emailed us these thoughts on non-adherence.
Details
By Mary Gabb (mary.gabb@rxcomms.com) As we reported in last month’s HOC, the past few years have witnessed a surge of interest in the role of adherence in health economics research,…
Details
By David Woods (david.woods@rxcomms.com) Writing in Pharmatech a couple of years ago, Dr Faiz Kermani observed that “many clinical trials are plagued by delays and setbacks that can cost pharmaceutical…
Details
By Ruth Whittington (ruth.whittington@rxcomms.com) The theme of this year’s ISPOR annual European Congress – the largest ever – was ‘Expanding Horizons’, and the Rx team took this very seriously, meeting…
Details
By David Woods (david.woods@rxcomms.com) Entusiasmo. That’s a word that describes, in his native Italian, what Vittorio Maio brings to his work in health policy and outcomes research. “What makes me…
Details
By David Woods (david.woods@rxcomms.com) Health clinics based in retail outlets, particularly drug stores, are changing the way primary care is delivered. Their proponents cite access, convenience, and price transparency as…
Details
